Speakers 
Director, Scientific and Regulatory Affairs, IFPMA, Switzerland
Janis leads cross-functional activities in regulatory science and international health policy for IFPMA, while partnering with policy experts and stakeholders to strengthen the pharmaceutical regulatory environment. She is responsible for guiding the organization’s regulatory team...
Read More →
Head of Regulatory Data Management, European Medicines Agency, Netherlands
I am responsible for Regulatory Master Data Management Services, currently on Substances, Products, Organisations and Referential data (also known as SPOR). I also coordinate the implementation of ISO IDMP in EU. I over 20 years of data management experience in the field of Medicines...
Read More →
Senior Advisor, Office of Regulatory Operations, CBER, FDA, United States
Ron Fitzmartin is a Senior Advisor in the Data Standards Branch, Office of Regulatory Operations, Center for Biologics Evaluation and Research, FDA. He provides policy and strategy consultation on electronic regulatory submissions and standardized data. Ron serves as Rapporteur for...
Read More →
Director/CEO, Uppsala Monitoring Centre, Sweden
Peter Hjelmström is the Director/CEO of Uppsala Monitoring Centre (UMC) and he has overall responsibility for the operations of the centre. Peter is physician and scientist, with MD and PhD degrees from Karolinska Institutet, and he did his postdoctoral fellowship at Yale University...
Read More →
Physician, Johns Hopkins University School of Medicine, United States
Joseph is a physician with a deep interest in drug regulatory policy and has previously published articles in venues like The New England Journal of Medicine, The Journal of the American Medical Association, and The Brookings Institution. His research interests include studying the...
Read More →
General Manager of the Office for Medicines, ANVISA, Brazil
General Manager of the Office of Medicines, responsible for evaluations off small molecules registrations and post-approval changes requests. Previously manager of Office for Quality Evaluation for Registration of Small Molecules and Manager of Office for Quality Evaluation of Small...
Read More →
Vice President, Global Head of Regulatory Intelligence & Policy, Boehringer Ingelheim, United States
Vada A. Perkins is Vice President. Global Head of Regulatory Policy & Intelligence for Boehringer Ingelheim. He is a former FDA Senior Advisor for Regulatory Science with international regulatory policy and strategy expertise in promoting convergence for the assessment of medicinal...
Read More →
Monday June 16, 2025 11:00am - 12:00pm
EDT
146BC
Walter E. Washington Convention Center 801 Allen Y. Lew Place, NW Washington, DC 20001-3614 USA
